Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03VZF
|
||||
| Former ID |
DNC006148
|
||||
| Drug Name |
4-hydroxy-3-nitrobenzaldehyde
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C7H5NO4
|
||||
| Canonical SMILES |
C1=CC(=C(C=C1C=O)[N+](=O)[O-])O
|
||||
| InChI |
1S/C7H5NO4/c9-4-5-1-2-7(10)6(3-5)8(11)12/h1-4,10H
|
||||
| InChIKey |
YTHJCZRFJGXPTL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 4-aminobutyrate aminotransferase, mitochondrial | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | GABA shunt | ||||
| Valine degradation | |||||
| Beta-alanine degradation | |||||
| 4-aminobutyrate degradation | |||||
| KEGG Pathway | Alanine, aspartate and glutamate metabolism | ||||
| Valine, leucine and isoleucine degradation | |||||
| beta-Alanine metabolism | |||||
| Propanoate metabolism | |||||
| Butanoate metabolism | |||||
| Metabolic pathways | |||||
| GABAergic synapse | |||||
| PANTHER Pathway | Aminobutyrate degradation | ||||
| Pyrimidine Metabolism | |||||
| Gamma-aminobutyric acid synthesis | |||||
| PathWhiz Pathway | Aspartate Metabolism | ||||
| Glutamate Metabolism | |||||
| Beta-Alanine Metabolism | |||||
| Valine, Leucine and Isoleucine Degradation | |||||
| Propanoate Metabolism | |||||
| WikiPathways | GABA synthesis, release, reuptake and degradation | ||||
| Alanine and aspartate metabolism | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2006 Feb;16(3):592-5. Epub 2005 Nov 14.Inhibition of GABA shunt enzymes' activity by 4-hydroxybenzaldehyde derivatives. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.